281 related articles for article (PubMed ID: 31955429)
21. Bezafibrate activation of PPAR drives disturbances in mitochondrial redox bioenergetics and decreases the viability of cells from patients with VLCAD deficiency.
Lund M; Andersen KG; Heaton R; Hargreaves IP; Gregersen N; Olsen RKJ
Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166100. PubMed ID: 33549744
[TBL] [Abstract][Full Text] [Related]
22. Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.
Bleeker JC; Kok IL; Ferdinandusse S; van der Pol WL; Cuppen I; Bosch AM; Langeveld M; Derks TGJ; Williams M; de Vries M; Mulder MF; Gozalbo ER; de Sain-van der Velden MGM; Rennings AJ; Schielen PJCI; Dekkers E; Houtkooper RH; Waterham HR; Pras-Raves ML; Wanders RJA; van Hasselt PM; Schoenmakers M; Wijburg FA; Visser G
J Inherit Metab Dis; 2019 May; 42(3):414-423. PubMed ID: 30761551
[TBL] [Abstract][Full Text] [Related]
23. Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.
Keeler AM; Conlon T; Walter G; Zeng H; Shaffer SA; Dungtao F; Erger K; Cossette T; Tang Q; Mueller C; Flotte TR
Mol Ther; 2012 Jun; 20(6):1131-8. PubMed ID: 22395529
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers.
Seminotti B; Leipnitz G; Karunanidhi A; Kochersperger C; Roginskaya VY; Basu S; Wang Y; Wipf P; Van Houten B; Mohsen AW; Vockley J
Hum Mol Genet; 2019 Mar; 28(6):928-941. PubMed ID: 30445591
[TBL] [Abstract][Full Text] [Related]
25. Very long-chain acyl-CoA dehydrogenase deficiency: the effects of accidental fat loading in a patient detected through newborn screening.
Ficicioglu C; Hussa C
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S187-90. PubMed ID: 19333779
[TBL] [Abstract][Full Text] [Related]
26. AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency.
Zieger M; Keeler AM; Flotte TR; ElMallah MK
J Inherit Metab Dis; 2019 Sep; 42(5):870-877. PubMed ID: 30993714
[TBL] [Abstract][Full Text] [Related]
27. Subclinical effects of long-chain fatty acid β-oxidation deficiency on the adult heart: A case-control magnetic resonance study.
Knottnerus SJG; Bleeker JC; Ferdinandusse S; Houtkooper RH; Langeveld M; Nederveen AJ; Strijkers GJ; Visser G; Wanders RJA; Wijburg FA; Boekholdt SM; Bakermans AJ
J Inherit Metab Dis; 2020 Sep; 43(5):969-980. PubMed ID: 32463482
[TBL] [Abstract][Full Text] [Related]
28. Exogenous ketosis elevates circulating erythropoietin and stimulates muscular angiogenesis during endurance training overload.
Poffé C; Robberechts R; Van Thienen R; Hespel P
J Physiol; 2023 Jun; 601(12):2345-2358. PubMed ID: 37062892
[TBL] [Abstract][Full Text] [Related]
29. Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection.
Tarasenko TN; Cusmano-Ozog K; McGuire PJ
Mol Genet Metab; 2018 Sep; 125(1-2):144-152. PubMed ID: 30031688
[TBL] [Abstract][Full Text] [Related]
30. Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Ørngreen MC
Dan Med J; 2016 Jul; 63(7):. PubMed ID: 27399985
[TBL] [Abstract][Full Text] [Related]
31. The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
Wehbe Z; Alatibi K; Jellusova J; Spiekerkoetter U; Tucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1591-1605. PubMed ID: 31394165
[TBL] [Abstract][Full Text] [Related]
32. Adult-onset very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD).
Fatehi F; Okhovat AA; Nilipour Y; Mroczek M; Straub V; Töpf A; Palibrk A; Peric S; Rakocevic Stojanovic V; Najmabadi H; Nafissi S
Eur J Neurol; 2020 Nov; 27(11):2257-2266. PubMed ID: 32558070
[TBL] [Abstract][Full Text] [Related]
33. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
[TBL] [Abstract][Full Text] [Related]
34. Patients with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fat during exercise but no effect of L-carnitine supplementation.
Madsen KL; Preisler N; Orngreen MC; Andersen SP; Olesen JH; Lund AM; Vissing J
J Clin Endocrinol Metab; 2013 Apr; 98(4):1667-75. PubMed ID: 23426616
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
[TBL] [Abstract][Full Text] [Related]
36. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
[TBL] [Abstract][Full Text] [Related]
37. Exogenous ketosis impacts neither performance nor muscle glycogen breakdown in prolonged endurance exercise.
Poffé C; Ramaekers M; Bogaerts S; Hespel P
J Appl Physiol (1985); 2020 Jun; 128(6):1643-1653. PubMed ID: 32407242
[TBL] [Abstract][Full Text] [Related]
38. PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.
Djouadi F; Bastin J
J Inherit Metab Dis; 2008 Apr; 31(2):217-25. PubMed ID: 18392740
[TBL] [Abstract][Full Text] [Related]
39. Complicated peripartum course in a patient with very long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency.
Akar HT; Çağan M; Yıldız Y; Sivri HS
Neuromuscul Disord; 2021 Jun; 31(6):566-569. PubMed ID: 33965301
[TBL] [Abstract][Full Text] [Related]
40. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.
Diekman EF; van Weeghel M; Wanders RJ; Visser G; Houten SM
FASEB J; 2014 Jul; 28(7):2891-900. PubMed ID: 24648546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
